HPV vaccine reminders and guidance for parents of 11–12-year-olds
Part of Infections clinical trials.
This study tests whether real-time reminders and guidance help families stay on track with the HPV vaccine for children who are 11–12 years old. It’s a “feasibility” study, meaning it focuses on whether the approach is practical and acceptable.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a parent of a child who is 11–12 years old
- You must be part of a clinic where providers see 11–12-year-olds for this study
- You, your adolescent, and the care team must agree to join (consent)
- You and your adolescent must be able to read and speak English
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to help prevent HPV-related cancers by increasing HPV vaccination rates in rural areas. It is for parents of 8- to 12-year-olds who have not yet completed the two-dose HPV vaccine series.
This study looks at ways to make it easier for preteens aged 10 to 12 to get the HPV vaccine, which protects against certain cancers. It aims to see if simple reminders or education can increase vaccination rates.
This trial asks mothers or female guardians who have some concerns about the HPV vaccine to share their stories. The goal is to create messages that help other parents make informed decisions about the vaccine for their children.
This study tests a program designed to help primary care practices increase HPV vaccination rates among adolescents aged 9 to 12 who haven't yet been vaccinated. It aims to find out if providing practices with resources and support can lead to more kids getting the HPV vaccine.
This study looks at whether training pharmacy staff in communication and vaccination workflows can improve HPV vaccine recommendations and uptake. If you are a parent or guardian of a child aged 9–17 who has not yet completed the HPV vaccine series, you may be eligible to participate.
This study helps researchers understand why some teenage girls and their families choose or don't choose HPV vaccination, and tests a new way to support families in making this decision together. The HPV vaccine helps prevent certain cancers later in life.
Hear when a new Human Papillomavirus (HPV) Vaccines trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.